The impact of structural uncertainty on cost effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease specific model standardization and improved guidance

GWJ (Geert) Frederix, JGC van Hasselt, JHM (Jan) Schellens, AM Hovels, JAM Raaijmakers, ADR Huitema, Hans Severens

Research output: Contribution to journalArticleAcademicpeer-review

27 Citations (Scopus)
7 Downloads (Pure)
Original languageEnglish
Pages (from-to)47-61
Number of pages15
JournalPharmacoeconomics (Print)
Publication statusPublished - 2014

Cite this